GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022

The company’s press release may be found here from PR Newswire.

Lewis & Clark

Lewis & Clark Ventures was founded by former operators with the conviction that innovation and entrepreneurial talent are plentiful outside of traditional capital centers. We partner with high potential Late Seed and Series A stage B2B software companies. Our vision for success is to become a trusted partner to every entrepreneur that we back and assist in their journey towards scale and significance.

Previous
Previous

Michael Rockhold joins Lewis & Clark Ventures as Principal

Next
Next

MedAvail Appoints New CEO, Announces Changes to Executive Board